Catalyst Wire Dossier Catalyst Wire Dossier

Fragmin (dalteparin)

dalteparin
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Fragmin (dalteparin), covering 2007-02-27 to 2007-02-27. Get the full timeline:

Most recent: Clinical Trial Update: The D-KAF (Dalteparin in Knee-to-Ankle Fracture) Trial [Phase 4]

See pricing